I. TERMINATED AGREEMENTS

SkyePharma
plc
(UK; SKYE)

Endo Pharmaceuticals Inc. (ENDP)

They ended a deal for the joint development of Propofol IDD-D, an injectable anesthetic and sedative product candidate

Endo backed out of the December 2002 deal, saying the product had a low likelihood of achieving the targeted drug profile; SkyePharma was evaluating its options on the product (4/21)


Notes:

* Private companies are indicated with an asterisk.

Unless otherwise noted, stock symbols listed are on the Nasdaq market.

No Comments